Search Results - "Burley TA"

DUSP8 as a regulator of glioblastoma stem-like cell contribution to tumor vascularization.

Authors: Castellani, Giorgia Buccarelli, Mariachiara D'Alessandris, Quintino Giorgio et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 9/30/2025, Vol. 44 Issue 1, p1-16. 16p.

Function of NLRP3 inflammasome activation in multiple myeloma.

Authors: Zhu, Xiaorong Yu, Jie Hua, Mingqiang et al.

Source: Hematology. Dec2024, Vol. 29 Issue 1, p1-8. 8p.

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].

Authors: Gibson, David Vo, Anh Huan Lambing, Hannah et al.

Source: BMC Neurology. 3/23/2024, Vol. 24 Issue 1, p1-13. 13p.

Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation.

Authors: Sup Kim Kyung Hwan Kim Hee-won Jung et al.

Source: Journal of Cancer. 2025, Vol. 16 Issue 3, p802-811. 10p.

Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.

Authors: Deng, Longfei Ren, Jie Li, Benqin et al.

Source: BMC Genomics. 12/6/2023, Vol. 24 Issue 1, p1-13. 13p.

Unraveling tissue-specific molecular targets of dihydroartemisinin in non-small cell lung cancer: an integrative machine learning and network pharmacology approach.

Authors: Zhou Q Shen E Hu J et al.

Source: Medical oncology (Northwood, London, England) [Med Oncol] 2025 Dec 24; Vol. 43 (2), pp. 60. Date of Electronic Publication: 2025 Dec 24.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

Autocrine regulation of tumor cell repopulation by Hsp70-HMGB1 alarmin complex.

Authors: Sverchinsky, Dmitry V. Alhasan, Bashar A. Mikeladze, Marina A. et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 10/25/2023, Vol. 42 Issue 1, p1-19. 19p.

Carboxymethyl Chitosan and Its Derivatives in Tissue Engineering.

Authors: Borsagli, Fernanda G. L. Medeiros¹ fernanda.borsagli@ufvjm.edu.br

Source: Advances in Polymer Science. 2023, Vol. 292, p257-280. 24p.

Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research.

Authors: Foruzandeh, Zahra Alivand, Mohammad Reza Ghiami-Rad, Mehdi et al.

Source: BMC Research Notes. 5/8/2023, Vol. 16 Issue 1, p1-12. 12p.

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.

Authors: Szopa W Burley TA Kramer-Marek G et al.

Source: BioMed research international [Biomed Res Int] 2017; Vol. 2017, pp. 8013575. Date of Electronic Publication: 2017 Feb 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101600173 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE

Community economic factors influence outcomes for patients with primary malignant glioma.

Authors: Bower, Aaron Hsu, Fang-Chi Weaver, Kathryn E et al.

Source: Neuro-Oncology Practice. Aug2020, Vol. 7 Issue 4, p453-460. 8p.

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.

Authors: Wang, Dongjiao Jiang, Yuxue Wang, Tie et al.

Source: BMC Medical Genomics. 5/12/2022, Vol. 15 Issue 1, p1-11. 11p.

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.

Authors: Mączyńska, Justyna Raes, Florian Da Pieve, Chiara et al.

Source: BMC Medicine. 5/3/2022, Vol. 20 Issue 1, p1-17. 17p.

Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.

Authors: Zhang, Zhe-Ao Xin, Xin Liu, Chao et al.

Source: Journal of Nanobiotechnology. 12/28/2021, Vol. 19 Issue 1, p1-24. 24p.

LncRNAs unraveling their sponge role in glioblastoma and potential therapeutic applications.

Authors: CAIJUAN LIU XINGHAO LI YUXUAN WU et al.

Source: Biocell. 2024, Vol. 48 Issue 3, p387-401. 15p.

Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.

Authors: Saadeh, Fadi S. Morsi, Rami Z. El-Kurdi, Abdallah et al.

Source: PLoS ONE. 11/25/2020, Vol. 16 Issue 11, p1-14. 14p.

Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.

Authors: Wang, Zhongze Cai, Huarui Li, Zekun et al.

Source: Clinical Epigenetics. 12/13/2023, Vol. 15 Issue 1, p1-18. 18p.

99mTc-radiolabeled imidazo[2,1-b]benzothiazole derivatives as potential radiotracers for glioblastoma.

Authors: Nosrati, Sahar Molavipordanjani, Sajjad Emami, Saeed et al.

Source: Journal of Radioanalytical & Nuclear Chemistry. Jan2020, Vol. 323 Issue 1, p205-211. 7p. 1 Diagram, 1 Chart, 4 Graphs.

Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis.

Authors: Karami, Elham Soliman, Hany Ruschin, Mark et al.

Source: Scientific Reports. 12/27/2019, Vol. 9 Issue 1, p1-11. 11p.

System-based approaches as prognostic tools for glioblastoma.

Authors: Salvucci, Manuela Zakaria, Zaitun Carberry, Steven et al.

Source: BMC Cancer. 11/12/2019, Vol. 19 Issue 1, p1-17. 17p. 3 Charts, 4 Graphs.